{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T15:44:58Z","timestamp":1787931898180,"version":"build-2784847793"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T00:00:00Z","timestamp":1575849600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.bcp.2019.113747","type":"journal-article","created":{"date-parts":[[2019,12,9]],"date-time":"2019-12-09T20:42:10Z","timestamp":1575924130000},"page":"113747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1)"],"prefix":"10.1016","volume":"172","author":[{"given":"Anna","family":"Vlachodimou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Konstantinopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan P.","family":"IJzerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura H.","family":"Heitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"606","key":"10.1016\/j.bcp.2019.113747_b0005","article-title":"Emerging Roles of Nucleoside Transporters","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113747_b0010","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s002100000308","article-title":"Signaling by extracellular nucleotides and nucleosides","volume":"362","author":"Illes","year":"2000","journal-title":"Naunyn-Schmiedeberg\u2019s Arch. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113747_b0015","series-title":"Biochemistry","author":"Berg","year":"2012"},{"key":"10.1016\/j.bcp.2019.113747_b0020","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.00627","article-title":"Who is who in adenosine transport","volume":"9","author":"Pastor-Anglada","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0025","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/15257770.2016.1210805","article-title":"Equilibrative nucleoside transporters-A review","volume":"36","author":"Boswell-Casteel","year":"2017","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"issue":"5","key":"10.1016\/j.bcp.2019.113747_b0030","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/S0028-3908(00)00207-0","article-title":"Distinct regional distribution of human equilibrative nucleoside transporter proteins 1 and 2 (hENT1 and hENT2) in the central nervous system","volume":"40","author":"Jennings","year":"2001","journal-title":"Neuropharmacology"},{"issue":"7","key":"10.1016\/j.bcp.2019.113747_b0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41594-019-0245-7","article-title":"Structures of human ENT1 in complex with adenosine reuptake inhibitors","volume":"26","author":"Wright","year":"2019","journal-title":"Nat. Struct. Mol. Biol."},{"issue":"19","key":"10.1016\/j.bcp.2019.113747_b0040","first-page":"4349","article-title":"Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines","volume":"58","author":"Mackey","year":"1998","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.bcp.2019.113747_b0045","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1128\/AAC.05762-11","article-title":"ENT1, a ribavirin transporter, plays a pivotal role in antiviral efficacy of ribavirin in a hepatitis C virus replication cell system","volume":"56","author":"Iikura","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"issue":"5","key":"10.1016\/j.bcp.2019.113747_b0050","first-page":"2804","article-title":"Myocardial protection by nucleoside transport inhibition","volume":"27","author":"Van Belle","year":"1995","journal-title":"Transpl. Proc."},{"key":"10.1016\/j.bcp.2019.113747_b0055","doi-asserted-by":"crossref","unstructured":"A. Khalil, F. Belal, A.A. Al-Badr, Dipyridamole: comprehensive profile, Profiles of drug substances, excipients, and related methodology 31 (2005) 215-80.","DOI":"10.1016\/S0099-5428(04)31007-5"},{"issue":"6","key":"10.1016\/j.bcp.2019.113747_b0060","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1182\/blood.V90.6.2345","article-title":"Dilazep, an antiplatelet agent, inhibits tissue factor expression in endothelial cells and monocytes","volume":"90","author":"Deguchi","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.bcp.2019.113747_b0065","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nrd.2015.18","article-title":"The drug\u2013target residence time model: a 10-year retrospective","volume":"15","author":"Copeland","year":"2015","journal-title":"Nat. Rev. Drug Discovery"},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0070","first-page":"31","article-title":"The role of binding kinetics in therapeutically useful drug action","volume":"12","author":"Swinney","year":"2009","journal-title":"Curr. Opin. Drug Discovery Dev."},{"issue":"10","key":"10.1016\/j.bcp.2019.113747_b0075","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.tips.2016.06.008","article-title":"In vivo target residence time and kinetic selectivity: the association rate constant as determinant","volume":"37","author":"de Witte","year":"2016","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0080","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/acschemneuro.7b00185","article-title":"Drug-target kinetics in drug discovery","volume":"9","author":"Tonge","year":"2017","journal-title":"ACS Chem. Neurosci."},{"issue":"4","key":"10.1016\/j.bcp.2019.113747_b0085","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cbpa.2010.06.176","article-title":"Drug-target residence time: critical information for lead optimization","volume":"14","author":"Lu","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113747_b0090","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.bcp.2015.09.019","article-title":"Thermodynamics and kinetics of inhibitor binding to human equilibrative nucleoside transporter subtype-1","volume":"98","author":"Rehan","year":"2015","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0095","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/0003-2697(85)90442-7","article-title":"Measurement of protein using bicinchoninic acid","volume":"150","author":"Smith","year":"1985","journal-title":"Anal. Biochem."},{"issue":"4","key":"10.1016\/j.bcp.2019.113747_b0100","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/biot.200800020","article-title":"The application of cell-based label-free technology in drug discovery","volume":"3","author":"Xi","year":"2008","journal-title":"Biotechnol. J."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0105","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1021\/ac051695v","article-title":"Real-time monitoring of morphological changes in living cells by electronic cell sensor arrays: an approach to study G protein-coupled receptors","volume":"78","author":"Yu","year":"2006","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bcp.2019.113747_b0110","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bios.2015.06.031","article-title":"Whole-cell biosensor for label-free detection of GPCR-mediated drug responses in personal cell lines","volume":"74","author":"Hillger","year":"2015","journal-title":"Biosens. Bioelectron."},{"issue":"12","key":"10.1016\/j.bcp.2019.113747_b0115","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1517\/17460441.2012.642360","article-title":"The development of label-free cellular assays for drug discovery","volume":"6","author":"Fang","year":"2011","journal-title":"Expert Opin. Drug Discovery"},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0120","doi-asserted-by":"crossref","first-page":"13802","DOI":"10.1038\/s41598-019-48829-3","article-title":"Label-free detection of transporter activity via GPCR signalling in living cells: a case for SLC29A1, the equilibrative nucleoside transporter 1","volume":"9","author":"Vlachodimou","year":"2019","journal-title":"Sci. Rep."},{"issue":"23","key":"10.1016\/j.bcp.2019.113747_b0125","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0026-895X(25)15016-5","article-title":"The kinetics of competitive radioligand binding predicted by the law of mass action","volume":"25","author":"Motulsky","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113747_b0135","first-page":"1","article-title":"Evaluation of enzyme inhibitors in drug discovery. A guide for medicinal chemists and pharmacologists","volume":"46","author":"Copeland","year":"2005","journal-title":"Methods Biochem. Anal."},{"key":"10.1016\/j.bcp.2019.113747_b0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.mce.2019.01.018","article-title":"Binding kinetics of ligands acting at GPCRs","volume":"485","author":"Sykes","year":"2019","journal-title":"Mol. Cell. Endocrinol."},{"issue":"7","key":"10.1016\/j.bcp.2019.113747_b0145","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/nchembio.1817","article-title":"Prolonged and tunable residence time using reversible covalent kinase inhibitors","volume":"11","author":"Bradshaw","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"15","key":"10.1016\/j.bcp.2019.113747_b0150","doi-asserted-by":"crossref","first-page":"5916","DOI":"10.1021\/acs.jmedchem.5b00518","article-title":"Structure\u2013affinity relationships (SARs) and structure\u2013kinetics relationships (SKRs) of Kv11.1 blockers","volume":"58","author":"Yu","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2019.113747_b0155","doi-asserted-by":"crossref","first-page":"18164","DOI":"10.1038\/srep18164","article-title":"TSPO ligand residence time: a new parameter to predict compound neurosteroidogenic efficacy","volume":"6","author":"Costa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2019.113747_b0160","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.bcp.2016.08.004","article-title":"Kinetic binding and activation profiles of endogenous tachykinins targeting the NK1 receptor","volume":"118","author":"Nederpelt","year":"2016","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0165","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.bcp.2005.10.031","article-title":"6-Benzylthioinosine analogues: Promising anti-toxoplasmic agents as inhibitors of the mammalian nucleoside transporter ENT1 (es)","volume":"71","author":"Gupte","year":"2005","journal-title":"Biochem. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113747_b0170","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.bcp.2003.09.018","article-title":"Glycine 154 of the equilibrative nucleoside transporter, hENT1, is important for nucleoside transport and for conferring sensitivity to the inhibitors nitrobenzylthioinosine, dipyridamole, and dilazep","volume":"67","author":"SenGupta","year":"2004","journal-title":"Biochem. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0175","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0922-4106(94)90209-7","article-title":"Nucleoside transport inhibition and platelet aggregation in human blood: R75231 and its enantiomers, draflazine and R88016","volume":"266","author":"Beukers","year":"1994","journal-title":"Eur. J. Pharmacol."},{"issue":"3","key":"10.1016\/j.bcp.2019.113747_b0180","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0922-4106(89)90057-6","article-title":"Inhibition of nucleoside transport by a new series of compounds related to lidoflazine and mioflazine","volume":"172","author":"IJzerman","year":"1989","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.bcp.2019.113747_b0185","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s002100000214","article-title":"Interaction of a series of draflazine analogues with equilibrative nucleoside transporters: species differences and transporter subtype selectivity","volume":"361","author":"Hammond","year":"2000","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.bcp.2019.113747_b0190","series-title":"Progress in Medicinal Chemistry","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0079-6468(09)04801-2","article-title":"Medicinal chemistry by the numbers: the physicochemistry, thermodynamics and kinetics of modern drug design","author":"Smith","year":"2009"},{"issue":"21","key":"10.1016\/j.bcp.2019.113747_b0195","doi-asserted-by":"crossref","first-page":"8746","DOI":"10.1021\/jm401219y","article-title":"Molecular basis for the long duration of action and kinetic selectivity of tiotropium for the muscarinic M3 receptor","volume":"56","author":"Tautermann","year":"2013","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.bcp.2019.113747_b0200","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/jpet.112.194456","article-title":"The Influence of receptor kinetics on the onset and duration of action and the therapeutic index of NVA237 and tiotropium","volume":"343","author":"Sykes","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"6","key":"10.1016\/j.bcp.2019.113747_b0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/nchembio.1796","article-title":"Translating slow-binding inhibition kinetics into cellular and in vivo effects","volume":"11","author":"Walkup","year":"2015","journal-title":"Nat. Chem. Biol."},{"issue":"6","key":"10.1016\/j.bcp.2019.113747_b0210","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1021\/acschembio.6b00074","article-title":"Conformational adaption may explain the slow dissociation kinetics of roniciclib (BAY 1000394), a type I CDK inhibitor with kinetic selectivity for CDK2 and CDK9","volume":"11","author":"Ayaz","year":"2016","journal-title":"ACS Chem. Biol."},{"issue":"24","key":"10.1016\/j.bcp.2019.113747_b0215","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1016\/j.bmcl.2014.10.026","article-title":"Dilazep analogues for the study of equilibrative nucleoside transporters 1 and 2 (ENT1 and ENT2)","volume":"24","author":"Playa","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"5","key":"10.1016\/j.bcp.2019.113747_b0220","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0026-895X(25)09663-4","article-title":"Inhibition and stimulation of photoreceptor phosphodiesterases by dipyridamole and M&B 22,948","volume":"36","author":"Gillespie","year":"1989","journal-title":"Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.bcp.2019.113747_b0225","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s002280050153","article-title":"Nucleoside transport inhibition by draflazine in unstable coronary disease","volume":"51","author":"Andersen","year":"1996","journal-title":"Eur. J. Clin. Pharmacol."},{"issue":"2","key":"10.1016\/j.bcp.2019.113747_b0230","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1476-5381.1993.tb13612.x","article-title":"The antiarrhythmic effects of the nucleoside transporter inhibitor, R75231, in anaesthetized pigs","volume":"109","author":"Wainwright","year":"1993","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113747_b0235","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.bcp.2018.07.014","article-title":"Impact of allosteric modulation: Exploring the binding kinetics of glutamate and other orthosteric ligands of the metabotropic glutamate receptor 2","volume":"155","author":"Doornbos","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.bcp.2019.113747_b0240","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.bcp.2018.03.018","article-title":"Structure-kinetic relationship studies of cannabinoid CB2 receptor agonists reveal substituent-specific lipophilic effects on residence time","volume":"152","author":"Soethoudt","year":"2018","journal-title":"Biochem. Pharmacol."},{"issue":"15","key":"10.1016\/j.bcp.2019.113747_b0245","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1021\/acs.jmedchem.7b00669","article-title":"Discovery and kinetic profiling of 7-aryl-1,2,4-triazolo[4,3-a]pyridines: positive allosteric modulators of the metabotropic glutamate receptor 2","volume":"60","author":"Doornbos","year":"2017","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.bcp.2019.113747_b0250","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/j.1476-5381.2010.00936.x","article-title":"Long-lasting target binding and rebinding as mechanisms to prolong in vivo drug action","volume":"161","author":"Vauquelin","year":"2010","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.bcp.2019.113747_b0255","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1517\/17460441.2015.1067196","article-title":"On the 'micro'-pharmacodynamic and pharmacokinetic mechanisms that contribute to long-lasting drug action","volume":"10","author":"Vauquelin","year":"2015","journal-title":"Expert Opin. Drug Discovery"}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304460?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295219304460?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T13:11:22Z","timestamp":1757769082000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295219304460"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":51,"alternative-id":["S0006295219304460"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113747","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Affinity, binding kinetics and functional characterization of draflazine analogues for human equilibrative nucleoside transporter 1 (SLC29A1)","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2019.113747","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"113747"}}